TMEM88B: A Potential Drug Target and Biomarker for Humans (G643965)

Target Name: TMEM88B

NCBI ID: G643965

TMEM88B

Other Name(s): TM88B_HUMAN | transmembrane protein 88B | Transmembrane protein 88B

TMEM88B: A Potential Drug Target and Biomarker for Humans

TMEM88B, also known as TM88B_HUMAN, is a protein that is expressed in various tissues of the human body. Its function and structure have been extensively studied, and its potential as a drug target or biomarker have been gaining interest in recent years. In this article, we will provide an overview of TMEM88B, its function, its potential drug target potential, and its potential as a biomarker.

Function and Structure of TMEM88B

TMEM88B is a 26kDa transmembrane protein that is expressed in various tissues of the human body, including the brain, heart, lungs, and kidneys. It is a member of the transmembrane protein family 8 (TMEM) and is characterized by a transmembrane domain and an extracellular domain. The transmembrane domain is responsible for the protein's maintainability and its ability to interact with other proteins, while the extracellular domain is involved in the protein's interactions with the cell surface and other cellular structures.

TMEM88B is involved in various physiological processes in the human body, including cell signaling, neurotransmitter release, and inflammation. It has been shown to play a role in the regulation of neurotransmitter release from neurons, and it has been linked to the development and progression of various neurological disorders, such as Alzheimer's disease and Parkinson's disease.

Potential Drug Target Potential

TMEM88B's potential as a drug target is due to its unique structure and its involvement in various physiological processes in the human body. One of the most promising aspects of TMEM88B as a drug target is its role in neurotransmitter release and its involvement in the regulation of neurotransmitter release from neurons. This has led to the development of several compounds that have been shown to modulate TMEM88B's activity and have potential as neurotransmitter antagonists or regulators.

In addition to its involvement in neurotransmitter release, TMEM88B has also been shown to be involved in inflammation and immune responses. This has led to the development of compounds that have been shown to modulate TMEM88B's activity in these processes and have potential as anti-inflammatory or immune system regulators.

Potential Biomarker

TMEM88B has also been shown to be a potential biomarker for various diseases, including neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. This is due to its expression and its involvement in the regulation of cellular processes that are affected in these disorders.

TMEM88B has been shown to be involved in the regulation of neurotransmitter release, which is a critical process for the function of many neurons. The regulation of neurotransmitter release is affected in various neurodegenerative disorders, and this has led to the development of compounds that have been shown to modulate TMEM88B's activity and have potential as neurotransmitter antagonists or regulators.

Conclusion

In conclusion, TMEM88B is a protein that is expressed in various tissues of the human body and is involved in various physiological processes. Its unique structure and its involvement in the regulation of neurotransmitter release and inflammation make it a promising target for drug development. The potential of TMEM88B as a drug target or biomarker has been gaining interest in recent years, and further research is needed to fully understand its function and its potential as a therapeutic tool.

Protein Name: Transmembrane Protein 88B

The "TMEM88B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM88B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets